Intellia Therapeutics Inc (NTLA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$8.00

Buy

$8.80

arrow-down$-0.40 (-4.52%)

Prices updated at 05 May 2025, 10:00 EDT

Prices minimum 15 mins delay

Prices in USD

Intellia Therapeutics Inc is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system.

NASDAQ

-0.74%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$8.81 - $8.43
	$28.18 - $5.90
	-
	874.24m
	-
	-
	412
	1.00
	2,411,532.20
	1.82
	102.03m
	US45826J1051
	-5.25
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.